JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Cogent Communications
CCOI
$433M
| $10.3M | ﹤0.01% |
133,664
-15,318
| -10% | -$1.22M |
2015 Q1
39 quarters
|
|
2602
PUT
Enterprise Products Partners
EPD
$78.1B
| $10.3M | ﹤0.01% |
328,300
| – | – |
2021 Q2
14 quarters
|
|
2603
DXC Technology
DXC
$1.77B
| $10.3M | ﹤0.01% |
515,098
-308,093
| -37% | -$6.5M |
2017 Q2
30 quarters
|
|
2604
Materion
MTRN
$6.5B
| $10.3M | ﹤0.01% |
103,799
+42,414
| +69% | +$4.61M |
2016 Q4
32 quarters
|
|
2605
Janux Therapeutics
JANX
$1.04B
| $10.3M | ﹤0.01% |
191,603
+173,211
| +942% | +$9.16M |
2021 Q2
14 quarters
|
|
2606
PUT
United Parcel Service
UPS
$79.1B
| $10.3M | ﹤0.01% |
81,300
+40,000
| +97% | +$5.26M |
2016 Q4
32 quarters
|
|
2607
Merchants Bancorp
MBIN
$2.29B
| $10.2M | ﹤0.01% |
280,942
+56,514
| +25% | +$2.28M |
2017 Q4
28 quarters
|
|
2608
DXP Enterprises
DXPE
$3.01B
| $10.2M | ﹤0.01% |
123,986
+25,942
| +26% | +$1.7M |
2013 Q2
46 quarters
|
|
2609
Roku
ROKU
$22.6B
| $10.2M | ﹤0.01% |
137,782
-629,967
| -82% | -$47.7M |
2018 Q1
27 quarters
|
|
2610
IPG Photonics
IPGP
$3.58B
| $10.2M | ﹤0.01% |
140,771
-10,371
| -7% | -$797K |
2015 Q4
36 quarters
|
|
|
ONC
2611
BeOne Medicines Ltd
ONC
$40.5B
| $10.2M | ﹤0.01% |
55,359
+45,579
| +466% | +$9.31M |
2017 Q4
28 quarters
|
|
2612
Bel Fuse Inc Class A
BELFA
$3.02B
| $10.2M | ﹤0.01% |
113,291
+45,710
| +68% | +$4.52M |
2024 Q1
3 quarters
|
|
2613
Dentsply Sirona
XRAY
$1.73B
| $10.2M | ﹤0.01% |
537,407
-1,309,982
| -71% | -$27.7M |
2013 Q2
46 quarters
|
|
2614
Sprott Physical Gold and Silver Trust
CEF
$7.27B
| $10.2M | ﹤0.01% |
428,822
+240,865
| +128% | +$5.97M |
2018 Q1
27 quarters
|
|
2615
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.01B
| $10.2M | ﹤0.01% |
254,749
-33,085
| -11% | -$1.57M |
2022 Q2
10 quarters
|
|
2616
CALL
Coca-Cola
KO
$369B
| $10.2M | ﹤0.01% |
163,300
-60,000
| -27% | -$3.92M |
2014 Q3
41 quarters
|
|
2617
Sensata Technologies
ST
$6.33B
| $10.2M | ﹤0.01% |
370,586
-289,982
| -44% | -$9.42M |
2013 Q2
46 quarters
|
|
2618
Business First Bancshares
BFST
$1.01B
| $10.1M | ﹤0.01% |
394,331
-13,470
| -3% | -$362K |
2018 Q2
26 quarters
|
|
2619
MasterBrand
MBC
$1.43B
| $10.1M | ﹤0.01% |
693,220
+398,303
| +135% | +$6.79M |
2022 Q4
8 quarters
|
|
2620
CALL
Marriott International
MAR
$93.6B
| $10.1M | ﹤0.01% |
36,300
+100
| +0.3% | +$27.5K |
2024 Q2
2 quarters
|
|
2621
iShares US Financials ETF
IYF
$3.92B
| $10.1M | ﹤0.01% |
91,448
+46,095
| +102% | +$5.13M |
2013 Q2
46 quarters
|
|
2622
Ashland
ASH
$3.18B
| $10.1M | ﹤0.01% |
141,499
-28,119
| -17% | -$2.25M |
2013 Q2
46 quarters
|
|
2623
Clear Channel Outdoor Holdings
CCO
$1.22B
| $10.1M | ﹤0.01% |
7,371,308
+610,110
| +9% | +$932K |
2013 Q2
46 quarters
|
|
2624
Napco Security Technologies
NSSC
$1.29B
| $10.1M | ﹤0.01% |
283,812
+216,017
| +319% | +$8.29M |
2017 Q4
28 quarters
|
|
2625
Vital Farms
VITL
$389M
| $10.1M | ﹤0.01% |
266,977
+579
| +0.2% | +$20.6K |
2020 Q3
17 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.